BIOPHARMA CONGRESS II

November 4, 2016

Election Impact On Biopharma in 2017

Ritz-Carlton Washington, DC

1150 22nd Street, NW

 

PRESENTED BY PREVISION POLICY + Friends Of Cancer RESEARCH

the future of Medicare part b. approval standards. cures. exchange formulary standards. medicare coverage. medicaid expansion. new technology payments. 

 

 

CONFIRMED 2016 SPEAKERS

ANDY SLAVITT (ACTING CMS ADMINISTRATOR)

ROBERT CALIFF (FDA COMMISSIONER)

JANET WOODCOCK (CDER)

PETER MARKS (CBER)

AMY BASSANO (CMS/CMMI)

FDA: JOHN JENKINS * RICHARD PAZDUR

JOSHUA SHARFSTEIN (JOHNS HOPKINS)

CMS: TAMARA SYREK JENSEN * JOSEPH CHIN

ICER'S STEVE PEARSON

 

LEAD 2016 SPONSOR

 

BIOPHARMA CONGRESS 2016 SPONSORS 

 

agenda

view our agenda of regulators, policy makers, and drug developers

Learn More →

Register

space is limited. register now.

Find Out How →